Unichem Laboratories Limited
Unichem Laboratories Limited Fundamental Analysis
Unichem Laboratories Limited (UNICHEMLAB.NS) shows strong financial fundamentals with a PE ratio of 8.50, profit margin of 13.32%, and ROE of 12.12%. The company generates $22.1B in annual revenue with strong year-over-year growth of 27.37%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 70.0/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze UNICHEMLAB.NS's fundamental strength across five key dimensions:
Efficiency Score
WeakUNICHEMLAB.NS struggles to generate sufficient returns from assets.
Valuation Score
ExcellentUNICHEMLAB.NS trades at attractive valuation levels.
Growth Score
ModerateUNICHEMLAB.NS shows steady but slowing expansion.
Financial Health Score
ExcellentUNICHEMLAB.NS maintains a strong and stable balance sheet.
Profitability Score
WeakUNICHEMLAB.NS struggles to sustain strong margins.
Key Financial Metrics
Is UNICHEMLAB.NS Expensive or Cheap?
P/E Ratio
UNICHEMLAB.NS trades at 8.50 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, UNICHEMLAB.NS's PEG of 0.04 indicates potential undervaluation.
Price to Book
The market values Unichem Laboratories Limited at 1.03 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 4.52 times EBITDA. This is generally considered low.
How Well Does UNICHEMLAB.NS Make Money?
Net Profit Margin
For every $100 in sales, Unichem Laboratories Limited keeps $13.32 as profit after all expenses.
Operating Margin
Core operations generate 4.20 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $12.12 in profit for every $100 of shareholder equity.
ROA
Unichem Laboratories Limited generates $8.29 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Unichem Laboratories Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Unichem Laboratories Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
UNICHEMLAB.NS converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
8.50
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.04
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.03
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.13
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.21
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.99
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.12
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.04
vs 25 benchmark
How UNICHEMLAB.NS Stacks Against Its Sector Peers
| Metric | UNICHEMLAB.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 8.50 | 29.45 | Better (Cheaper) |
| ROE | 12.12% | 779.00% | Weak |
| Net Margin | 13.32% | -24936.00% (disorted) | Strong |
| Debt/Equity | 0.21 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 1.99 | 4.65 | Neutral |
| ROA | 8.29% | -19344.00% (disorted) | Weak |
UNICHEMLAB.NS outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Unichem Laboratories Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
81.91%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
327.73%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
-135.30%
Industry Style: Defensive, Growth, Innovation
Declining